07:00 , Oct 20, 2014 |  BC Week In Review  |  Company News

Xagenic management update

Xagenic Inc. , Toronto, Ontario   Business: Diagnostic   Departed: Bruce Cohen as executive chairman   Hired: Timothy Still as president, CEO and a director, formerly president and CEO of Accumetrics Inc. , which merged...
07:00 , Sep 12, 2011 |  BC Week In Review  |  Clinical News

VerifyNow P2Y12 assay regulatory update

The European Society of Cardiology (ESC) updated its guidelines for managing acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation to include a Class IIb recommendation stating that platelet function testing may be...
07:00 , Sep 5, 2011 |  BC Week In Review  |  Clinical News

VerifyNow P2Y12 assay: Pivotal trial additional data

A post hoc analysis of 2,796 patients in the double-blind, North American pivotal GRAVITAS trial showed that patients with platelet reactivity <208 P2Y12 reaction units (PRU) while on Plavix clopidogrel experienced a significantly lower risk...
07:00 , May 23, 2011 |  BC Week In Review  |  Clinical News

VerifyNow P2Y12 assay regulatory update

Accumetrics received CE Mark approval in the EU for its VerifyNow P2Y12 assay to identify patients with high residual platelet reactivity on antiplatelet therapy at risk for cardiovascular events. The company said it will launch...
08:00 , Dec 6, 2010 |  BC Week In Review  |  Clinical News

VerifyNow P2Y12 assay: Pivotal trial data

The double-blind, placebo-controlled, North American pivotal GRAVITAS trial in 2,214 evaluable patients with high residual platelet reactivity as measured by Accumetrics' VerifyNow P2Y12 assay after PCI showed that maintenance therapy with 150 mg/day Plavix clopidogrel...
07:00 , Sep 6, 2010 |  BC Week In Review  |  Financial News

Accumetrics financial update

Accumetrics raised $7 million in final close an undisclosed round, bringing the total raised in the round to $24 million. Existing investors Arnerich Massena; BBT Fund/Apothecary Capital; Essex Woodlands Health Ventures; Rivervest Venture Partners; and...
07:00 , Oct 12, 2009 |  BC Week In Review  |  Financial News

Accumetrics completes venture financing

Accumetrics Inc. , San Diego, Calif.   Business: Pharmacogenetics   Date completed: 10/6/09   Type: Venture financing   Raised: $16.5 million   Investors: Arnerich Massena; BBT Fund/Apothecary Capital; Essex Woodlands Health Ventures; Kaiser Permanente Ventures;...
00:38 , Oct 7, 2009 |  BC Extra  |  Financial News

Accumetrics raises $16.5M

Diagnostic company Accumetrics Inc. (San Diego, Calif.) raised $16.5 million in a venture round led by existing investor Arnerich Massena. Existing investors BBT Fund/Apothecary Capital; Essex Woodlands Health Ventures; Kaiser Permanente Ventures; and RiverVest Venture...
08:00 , Nov 17, 2008 |  BC Week In Review  |  Company News

Accumetrics management update

Accumetrics Inc. , San Diego, Calif.   Business: Pharmacogenetics   Hired: John Young as CMO, while remaining a professor of medicine and director of the cardiovascular innovations program at the Ohio State University  ...
07:00 , Oct 27, 2008 |  BioCentury  |  Finance

Ebb & Flow

Drug delivery and infectious disease company...